In this invention Paradigm Biopharmaceuticals presents a method of inhibiting or reducing Nerve Growth Factor (NGF) or pro-Nerve Growth Factor (pro-NGF) activity by administering a polysulfated polysaccharide.

See the complete patent here: TREATMENT OF PAIN WITH POLYSULFATED POLYSACCHARIDES